Recursion Pharmaceuticals
RXRX
#4411
Rank
NZ$3.12 B
Marketcap
$10.73
Share price
1.27%
Change (1 day)
20.95%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: NZ$3.12 Billion

As of November 2024 Recursion Pharmaceuticals has a market cap of NZ$3.12 Billion. This makes Recursion Pharmaceuticals the world's 4411th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$3.12 B-7.07%
2023NZ$3.36 B46.22%
2022NZ$2.30 B-45.69%
2021NZ$4.23 B

End of Day market cap according to different sources

On Nov 2nd, 2024 the market cap of Recursion Pharmaceuticals was reported to be:

NZ$3.12 Billion
by Yahoo Finance info icon info icon
NZ$3.12 Billion
by CompaniesMarketCap info icon info icon
NZ$3.01 Billion
by Nasdaq info icon info icon